Back to search
Borderline Resectable/Unresectable Pancreatic Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Borderline Resectable/Unresectable Pancreatic Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Borderline Resectable/Unresectable Pancreatic Cancer trials you may qualify forThis early phase I trial aims to determine how cobimetinib, olaparib, onvansertib, azenosertib, AZD5305 or tremelimumab works in patients with pancreatic cancer…
The prognosis for patients with localized pancreatic adenocarcinoma who are not surgical candidates is poor. Patients characterized as having "borderline resect…
The purpose of this study is to determine if the combination of paclitaxel protein bound, gemcitabine, cisplatin, paricalcitol are effective in individuals with…
By doing this study, it is the hope to learn whether an injection of the measles, mumps, rubella (MMR) vaccine developed by Merck \& Co. (Merck's M-M-R® II) int…
This phase II trial evaluates whether early switching from modified fluorouracil/irinotecan/leucovorin/oxaliplatin (mFOLFIRINOX) chemotherapy regimen to a combi…